| 5.83 Data as of May 17 |  -0.03 / -0.51%Today’s Change | 4.35 Today|||52-Week Range 7.67 | -0.34% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $323.2M |
Raptor Pharmaceutical Corp. 9 Commercial Boulevard Novato California 94949-6137 |
| Individual stakeholders | 2.96% |
| Mutual fund holders | 18.99% |
| Other institutional | 14.42% |
| Christopher M. Starr, PhD | Chief Executive Officer & Director |
| Julie Anne Smith | Chief Operating Officer & Executive VP-Strategy |
| Georgia L. Erbez | Chief Financial Officer, Secretary & Treasurer |
| Patrice P. Rioux, MD, PhD | Chief Medical Officer-Clinical Development |
| Todd C. Zankel, PhD | Chief Scientific Officer |
.
